Funding for this research was provided by:
National Center for Advancing Translational Sciences (KL2 TR002379)
Received: 26 November 2018
Accepted: 2 April 2019
First Online: 1 May 2019
Ethics approval and consent to participate
: This study was reviewed and approved by the Mayo Clinic institutional review board.
: Not applicable.
: Author N.O. reports employment and travel expenses with Health Net and stock or other ownership with Centene; author C.V. reports a leadership role with and research funding from Grail, Inc. All other authors have no disclosures.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.